FDA Panel Gives Nod to Affymax Drug for Anemia
A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis. A Food and Drug Administration advisory panel voted 15-1 on Wednesday, with one abstention, that peginesatide's benefits outweighed ...
Nektar Reports Affymax Announced FDA Advisory Committee Voted in Favor of ...
Ahead of the Bell: Affymax shares climb
FDA Panel Backs Affymax Anemia Drug For Dialysis Patients - Update